Hydrogen and health / Gut, liver and pancreas
Hydrogen and hepatitis: what the studies say
The liver neutralises toxins and in the process produces free radicals itself. In randomised trials the authors observed better liver markers after hydrogen.
Hydrogen and hepatitis
We describe what was studied in humans and what the authors of the publications observed. We give the source for every study.
Typical symptoms
Studies
Human studies: 3 studies in the cards below, including 3 randomised.
On this page
What is hepatitis?
Hepatitis can be caused by viruses, alcohol, medicines or excess fat. It often runs without symptoms, and the only sign is raised liver tests. Untreated, it leads to fibrosis.
Symptoms of hepatitis
- Tiredness, weakness
- Lack of appetite, nausea
- Pain or a feeling of pressure under the right ribs
- Yellowing of the skin and the whites of the eyes, dark urine
- Often no symptoms: picked up in blood tests
When to see a doctor. Jaundice, dark urine and pale stools call for urgent investigation.
Hepatitis: what happens in the body
Damaged hepatocytes release signals that attract inflammatory cells. Free radicals destroy the membranes of liver cells and stimulate the laying down of connective tissue.
Hydrogen is not foreign to the body: gut bacteria produce it every day when they ferment fibre. The gut lining and liver cells are constantly exposed to oxidative stress linked to digestion, toxins and inflammation, and their tight barrier decides what gets into the blood.
Hydrogen and hepatitis: the studies we refer to
In people with fatty liver, the authors observed better lipid and liver enzyme results after 13 weeks of inhalation. In 136 people having chemotherapy, the authors observed no rise in the enzymes ALT and AST in the hydrogen water group, whereas it occurred in the placebo group.
What the studies say
Selected scientific publications on molecular hydrogen in humans: a description of each study, its results and a link to the source.
1Non-alcoholic fatty liver disease
randomised trialn = 43inhalation2022
Non-alcoholic fatty liver disease
- Participants
- People with NAFLD
- Protocol
- H2/O2 mixture for 13 weeks
- Result
- Improvement in lipids and liver enzymes; improvement in fat content on ultrasound/CT was found in the subgroup with moderate or severe NAFLD.
- Study context
- Randomised placebo-controlled study. Participants: 43.
Tao G i wsp.. A randomized, placebo-controlled clinical trial of hydrogen/oxygen inhalation for non-alcoholic fatty liver disease. Journal of cellular and molecular medicine 26(14): 4113-4123. 2022. PubMed 35734974 · DOI · Full text
2Liver protection during chemotherapy for colorectal cancer
Hydrogen waterrandomised trialn = 1362017
Liver protection during chemotherapy for colorectal cancer
- Participants
- 144 randomised; final analysis: 76 H2 and 60 placebo
- Protocol
- H2 water as an addition to the mFOLFOX6 chemotherapy regimen
- Result
- After chemotherapy, ALT, AST and indirect bilirubin rose in the placebo group, while in the hydrogen group they stayed at a similar level. The authors described this as a signal of liver protection.
- Study context
- RCT, single-blind. Participants: 136.
Yang Q i wsp.. Protective effect of hydrogen-rich water on liver function of colorectal cancer patients treated with mFOLFOX6 chemotherapy. Molecular and clinical oncology 7(5): 891-896. 2017. PubMed 29142752 · DOI · Full text
3Fatty liver assessed by MRI
Hydrogen waterrandomised trialn = 122019
Fatty liver assessed by MRI
- Participants
- People with overweight and mild/moderate NAFLD
- Protocol
- 1 l/day for 28 days vs placebo
- Result
- MRI showed a lower fat content in selected areas of the liver after H2 than after placebo (p<0.05).
- Study context
- Pilot crossover RCT, double-blind. Participants: 12.
Korovljev D i wsp.. Hydrogen-rich water reduces liver fat accumulation and improves liver enzyme profiles in patients with non-alcoholic fatty liver disease: a randomized controlled pilot trial. Clinics and research in hepatology and gastroenterology 43(6): 688-693. 2019. PubMed 30982748 · DOI
Educational information, not medical advice. Full database of publications: Hydrogen Studies.
A broader review of the research: Hydrogen and the liver: fatty liver and liver enzymes.
Hepatitis: what to know
Causes of hepatitis
- Hepatitis A, B, C and E viruses
- Alcohol
- Fatty liver in obesity and diabetes
- Medicines, herbs and supplements, and autoimmune diseases
Living with hepatitis
Chronic hepatitis often causes no symptoms apart from tiredness, so it is found by chance, in blood tests. The diagnosis means regular check-ups and caution with every new medicine.
How hepatitis is treated
Care depends on the cause: antiviral medicines, which in hepatitis C clear the virus in most people who take them, abstinence, weight loss or immunosuppressive medicines. A liver specialist monitors the enzymes and the degree of liver fibrosis.
What supports the liver
- Giving up alcohol
- Vaccination against hepatitis A and B
- A healthy body weight and caution with supplements
Hepatitis and hydrogen: frequently asked questions
If bacteria make hydrogen themselves, why inhale it?
The amount of hydrogen produced in the gut depends on diet and the make-up of the microbiota, and it varies a great deal. Inhalation delivers a known, repeatable amount that reaches the blood within several minutes.
Is it a medical device?
No. PRAGMA HYDROGEN is a device for wellness use. It does not replace a consultation with a doctor.
Is hydrogen inhalation safe?
In clinical trials, hydrogen inhalation was well tolerated. The generator has 8 safety features that stop it working if a fault occurs. Hydrogen is a flammable gas: do not smoke or use an open flame near the device. People with chronic conditions, pregnant women and children should consult a doctor before use.